Preliminary scientific tests show conolidine may well inhibit unique ion channels, lowering neuronal excitability and limiting suffering indicators. This system is particularly suitable in neuropathic ache, where by irregular signaling causes persistent soreness. Furthermore, conolidine seems to influence G protein-coupled receptor (GPCR) pathways